Climb Bio, Inc. (CLYM)
10.25
-0.08
(-0.77%)
USD |
NASDAQ |
Oct 30, 16:00
10.40
+0.15
(+1.46%)
After-Hours: 20:00
Climb Bio Free Cash Flow : -53.07M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -53.07M |
| March 31, 2026 | -53.49M |
| December 31, 2025 | -54.54M |
| September 30, 2025 | -44.43M |
| June 30, 2025 | -39.74M |
| March 31, 2025 | -29.18M |
| December 31, 2024 | -15.56M |
| September 30, 2024 | -10.99M |
| June 30, 2024 | 0.057M |
| March 31, 2024 | -7.241M |
| Date | Value |
|---|---|
| December 31, 2023 | -20.60M |
| September 30, 2023 | -28.10M |
| June 30, 2023 | -35.77M |
| March 31, 2023 | -41.77M |
| December 31, 2022 | -37.37M |
| September 30, 2022 | -36.80M |
| June 30, 2022 | -45.60M |
| March 31, 2022 | -40.11M |
| December 31, 2021 | -36.07M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Korsana Biosciences, Inc. | -4.517M |
| Cullinan Therapeutics, Inc. | -159.26M |
| Q32 Bio, Inc. | -19.83M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.55M |
| Cash from Investing (Quarterly) | -57.26M |
| Cash from Financing (Quarterly) | 103.70M |
| Free Cash Flow Per Share (Quarterly) | -0.1419 |
| Free Cash Flow to Equity (Quarterly) | -11.64M |
| Free Cash Flow to Firm (Quarterly) | -10.81M |
| Free Cash Flow Yield | -7.40% |